One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
The Science Behind Breathalyzers: How Alcohol Metabolism Tests WorkFebruary 26, 2024Do you ever wonder how breathalyzers are able to determine the level of alcohol in your system with just a simple breath test? The answer lies in understanding the science behind alcohol metabolism an...view
Why Choose Microarrays over Other Technologies?November 10, 2023Microarrays are becoming an increasingly popular choice for biologists and researchers worldwide. With the help of advanced technology, these arrays provide a cost-effective and efficient way to analy...view
Microbial Genome Sequencing's Impact on AgricultureFebruary 26, 2024Microbial genome sequencing has revolutionized the field of agriculture by providing valuable insights into the genetic makeup of microorganisms that play a crucial role in soil health, plant growth, ...view